WHO ICTRP trial
Study on the Pathogenesis of Vascular Endothelial Dysfunction in Type 2 diabetes…
ChiCTR2300079270 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2300079270 |
|---|---|
| Public title | Study on the Pathogenesis of Vascular Endothelial Dysfunction in Type 2 diabetes Based on the Arg1 Pathway of Red Blood Cell Exosomes |
| Scientific title | Study on the Pathogenesis of Vascular Endothelial Dysfunction in Type 2 diabetes Based on the Arg1 Pathway of Red Blood Cell Exosomes |
| Primary sponsor | Qingyuan People's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Basic Science |
| Countries | China |
| Conditions | Vascular endothelial dysfunction in diabetes |
| Interventions | patients with type 2 diabetes:None;Healthy subjects:None |
| Registration date | Dec 28, 2023 |
| Target size | patients with type 2 diabetes:40;Healthy subjects:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: